MannKind Corp
MNKD
#4917
Rank
$1.74 B
Marketcap
$5.68
Share price
-0.53%
Change (1 day)
-15.60%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): $30.78 Million USD

According to MannKind Corp's latest financial reports the company's current earnings are $0.31 Billion USD. In 2024 the company made an earning of $30.51 Million USD, an increase over its 2023 earnings that were of -$10.38 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $30.78 M0.87%
2024 $30.51 M-394.09%
2023 -$10.38 Million-88.13%
2022 -$87.4 Million8%
2021 -$80.93 Million40.84%
2020 -$57.46 Million10.7%
2019 -$51.91 Million-40.16%
2018 -$86.74 Million-26.04%
2017 -$0.12 Billion-193.33%
2016 $0.12 B-134.11%
2015 -$0.37 Billion85.72%
2014 -$0.2 Billion3.6%
2013 -$0.2 Billion12.79%
2012 -$0.17 Billion5.58%
2011 -$0.17 Billion-5.72%
2010 -$0.18 Billion-22.51%
2009 -$0.23 Billion-27.37%
2008 -$0.31 Billion3.36%
2007 -$0.3 Billion27.18%
2006 -$0.24 Billion101.63%
2005 -$0.12 Billion50.46%
2004 -$76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Halozyme Therapeutics
HALO
$0.74 B 2,323.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
$20.84 B 67,618.55%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Merck
MRK
$23.09 B 74,908.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$22.50 B 73,003.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-$0.12 Billion-469.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$11.85 B 38,401.77%๐Ÿ‡บ๐Ÿ‡ธ USA